Figure 3

Features associated with desmoplasia in low grade serous ovarian carcinoma. (A) Distribution of stage at diagnosis between tumours with desmoplasia (n = 40: 2 FIGO stage I, 1 stage II, 28 stage III, 9 stage IV) and without desmoplasia (n = 23: 7 stage I, 4 stage II, 11 stage III, 1 not evaluable). (B) Distribution of residual disease (RD) between tumours with desmoplasia (n = 40: 27 macroscopic RD, 13 zero visible RD) and without desmoplasia (n = 23: 7 macroscopic RD, 14 zero visible RD, 2 not evaluable). (C) Progesterone receptor (PR) expression between cases with and without desmoplasia (median PR histoscore 30 and 110, respectively). Desmo, desmoplastic; No des, no desmoplasia identified; zero RD, zero macroscopic residual disease after debulking surgery; macro RD, macroscopic residual disease after debulking surgery.